[Detecting multi-drug resistance of bladder cancer for the intravesical chemotherapy]

Zhonghua Wai Ke Za Zhi. 2004 Mar 7;42(5):285-7.
[Article in Chinese]

Abstract

Objective: To explore multi-drug resistance (MDR) of bladder cancer for the intravesical instillation.

Methods: Using immunohistochemical staining, in 44-case human bladder cancer cells, the expressions of P-glycoprotein (P-gp), glutathione S-transferase (GST-pi) and topoisomerase (TOPO-II), were detected to find out the resistance to drugs.

Results: P-gp had a higher expression in 54.5% cases. GST-pi had no or a lower expression in 65.9% cases. TOPO-II had a higher expression in 29.5% but a lower expression in 65.9% cases.

Conclusion: Detecting the factors of MDR in bladder cancer cells could help to choose drugs for intravesical chemotherapy.

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / analysis
  • Administration, Intravesical
  • Adult
  • Aged
  • DNA Topoisomerases, Type II / analysis
  • Drug Resistance, Multiple*
  • Drug Resistance, Neoplasm
  • Female
  • Glutathione Transferase / analysis
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Urinary Bladder Neoplasms / drug therapy*
  • Urinary Bladder Neoplasms / metabolism

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Glutathione Transferase
  • DNA Topoisomerases, Type II